Caxton Associates (New York)’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-25,725
| Closed | -$224K | – | 688 |
|
|
2023
Q1 | $224K | Sell |
25,725
-47,924
| -65% | -$418K | 0.03% | 394 |
|
|
2022
Q4 | $462K | Buy |
73,649
+14,225
| +24% | +$89.2K | 0.03% | 239 |
|
|
2022
Q3 | $208K | Sell |
59,424
-45,778
| -44% | -$160K | 0.03% | 380 |
|
|
2022
Q2 | $310K | Sell |
105,202
-12,700
| -11% | -$37.4K | 0.03% | 365 |
|
|
2022
Q1 | $367K | Buy |
+117,902
| New | +$367K | 0.03% | 298 |
|